Filing Details

Accession Number:
0001179110-10-017638
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-16 13:56:14
Reporting Period:
2010-12-14
Filing Date:
2010-12-16
Accepted Time:
2010-12-16 13:56:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198229 Paul Berg Beckman Center, Rm. B062
Stanford University School Of Medicine
Stanford CA 94305
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-14 20,000 $19.44 52,000 No 4 M Direct
Common Stock Disposition 2010-12-14 20,000 $36.93 32,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-12-14 20,000 $0.00 20,000 $19.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,000 2015-05-10 No 4 M Direct
Footnotes
  1. Options vested in full on May 10, 2005.
  2. Sale prices reported for the transactiion reported here range from $36.835 to $37.08. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.